Gammaherpesviruses are characterized biologically by their association with tumors in immunosuppressed hosts. The prototypic gamma-2 herpesvirus, herpesvirus saimiri (HVS), causes lymphomas in some primates and rabbits and can transform T lymphocytes (32, 37, 46, 50) . Epstein-Barr virus (EBV) is associated with lymphomas and nasopharyngeal carcinoma in humans (39, 60) , and Kaposi's sarcoma herpesvirus (KSHV) is associated with Kaposi's sarcoma, body cavity-based lymphomas, and Castleman's disease in humans (12, 15, 20, 34, 40, 49, 63) . Because EBV and KSHV have been found to be species specific, the only effective animal models for analysis of gammaherpesvirus pathogenesis have been HVS infection of primates or rabbits and EBV infection of marmosets. To help elucidate the pathogenesis of acute and chronic gammaherpesvirus infection, a mouse model of gammaherpesvirus infection has recently been developed.
Murine gammaherpesvirus 68 (␥HV68; also referred to as MHV68) is a natural pathogen of wild murid rodents (7), capable of infecting both outbred and inbred mice (8, 48, 58, 67) . Viral genome structure and limited sequence analysis have indicated that ␥HV68 is related to primate gammaherpesviruses (24, 25, 55, 64, 65) . ␥HV68 infects multiple organs of inbred mice and can establish a latent or persistent infection in the spleen (8, 58, 67, 68, 76) . Both CD4 and CD8 T cells are important for control of ␥HV68 infection (10, 26, 76) , with persistent rather than latent infection seen in CD8-deficient mice (76) and progressive infection seen in CD4-deficient mice (10) . One study implicated B lymphocytes as a potential reservoir of persistent and/or latent virus in infected mouse spleens (68) . In addition, a B-lymphoma cell line chronically infected with ␥HV68 has been isolated from an infected mouse (73) . However, the issue of the cellular reservoir for latent virus remains unclear since subsequent analyses has demonstrated efficient establishment of latency in mice lacking mature B cells (76) and persistence of ␥HV68 DNA in lungs of B-cell-deficient mice (74) , raising the possibility that there are multiple or alternate sites of ␥HV68 latency. In one study, a significant portion of mice infected with ␥HV68 developed lymphoproliferative disorders, and treatment with cyclosporin A increased the frequency of lymphoproliferative disease (66) . These initial studies strongly suggest that ␥HV68 is biologically similar to primate gammaherpesviruses. To establish a molecular basis for analysis of ␥HV68 pathogenesis, we have sequenced the ␥HV68 genome.
MATERIALS AND METHODS
Virus isolation and assay. ␥HV68 was kindly provided by Peter Doherty (St. Jude's Hospital, Memphis, Tenn.). We cloned ␥HV68 by limiting dilution twice and designated the isolate that we sequenced the ␥HV68 WUMS (for Washington University School of Medicine) clone. This strain has been submitted to the American type culture collection. NIH 3T12 and mouse embryonic fibroblasts (MEFs) were maintained in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum, penicillin (100 U/ml), streptomycin (100 mg/ml), and 2 mM L-glutamine. MEFs were obtained as previously described (57) . Plaque assays were performed on NIH 3T12 cells as previously described (76) .
Preparation of viral DNA. Virus stocks for preparation of DNA were grown (multiplicity of infection of 1.0) in mouse NIH 3T12 fibroblasts. Virus was harvested from the culture supernatants 4 to 6 days postinfection (three T225 tissue culture flasks of NIH 3T12 fibroblasts were infected for DNA preparation). Cellular debris was removed from the culture supernatant by centrifugation at 1,000 ϫ g for 20 min. Virus was pelleted by centrifugation at 14,000 ϫ g for 2 h at 4°C. The virus pellet was gently washed three times with 5 ml of cold phosphate-buffered saline and then resuspended in 1 ml of DNase I digestion buffer (50 mM Tris [pH 7.5], 10 mM MgCl 2 , 50 g of bovine serum albumin per ml) and adjusted to a final volume of 2 ml with DNase I digestion buffer. DNase I (Worthington) was added to a final concentration of 1.4 g/ml and allowed to digest for 30 min at 37°C. The virus suspension was then layered onto a 20% sucrose cushion (20% sucrose, 20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA) in TLS55 tubes (Beckman), and virus was pelleted at 111,000 ϫ g for 1 h at room temperature in a TLS55 swinging-bucket rotor (Beckman). The viral pellet was resuspended in 3 ml of 10 mM Tris (pH 8.0)-1 mM EDTA, and 3 ml of 2ϫ lysis buffer (40 mM Tris [pH 7.5], 200 mM NaCl, 20 mM EDTA, 2% Sarkosyl, 0.5% sodium dodecyl sulfate) was added. Proteinase K was added to a final concentration of 333 g/ml, and the reaction mixture was incubated at 37°C overnight. The reaction mixture was then gently extracted with an equal volume phenol-chloroform (1:1, vol/vol) by rocking for 30 min, followed by centrifugation at 3,000 ϫ g for 10 min. The aqueous phase was reextracted with an equal volume of chloroform by rocking for 30 min and centrifuged to separate the phases. The aqueous phase was recovered, and viral DNA was precipitated by addition of sodium acetate to a final concentration of 0.3 M and 2 volumes of ethanol. DNA was analyzed by pulsed-field gel electrophoresis and shown to migrate as a single large band.
To ensure that the DNA isolated contained all sequences required for ␥HV68 replication, we transfected the full-length DNA into NIH 3T12 fibroblast cells by the calcium phosphate-dimethyl sulfoxide shock method (11) . In two independent experiments, transfection of the purified viral DNA generated infectious ␥HV68 (not shown). As a control, we showed that no infectious virus was present in the viral DNA preparation by the absence of viral cytopathic effect in MEF cultures to which viral DNA was added (without transfection). The MEF assay used is 10-fold more sensitive for detecting infectious ␥HV68 than the plaque assay on NIH 3T12 fibroblasts (76) .
DNA sequence generation. Purified viral DNA was sheared by sonication; ends were blunted with mung bean nuclease, size fractionated by gel electrophoresis, purified, ligated into M13 vector restricted with SmaI, and phosphatase treated as described elsewhere (77) . Single-stranded DNA from M13 subclones was prepared by using the modified high-throughput ThermoMAX procedure (45) . The single-stranded DNA was sequenced by using a cycling protocol (30) with fluorescent dye-labeled ET primers (35) and Thermosequenase (Amersham Inc., Arlington Heights, Ill.). Reaction products were analyzed on ABI 373A (stretch modified) and 377 automated sequencers (77) . DNA sequence data was processed by using the OTTO script (33a). Base calling and sequence assembly were performed by using PHRED and CONSED (32a) followed by XGAP (19) . The program FINISH (45a) was used to analyze the initial assembly in order to generate a list of specific reads necessary to obtain complementary strand coverage, close gaps, and resolve ambiguities. All final reads necessary to complete the genome sequence were performed and entered into the database (77) . The entire sequence was represented by coverage either on both strands or with orthologous chemistries to resolve any ambiguities. The sequence data for the two tandem repeats were derived as discussed elsewhere in this report. Sequence assemblies were verified by constructing EcoRI, HindIII, and BamHI maps of the assembled sequence and comparing them with the published maps of the ␥HV68 genome (25) .
To obtain sequences within the 100-bp internal repeat, the HindIII (95,678 bp)-EcoRI (102,216 bp) fragment of the genome containing the repeat was cloned into BlueScript KSϩ (Stratagene). This clone was digested with NheI (cuts at 101,676 bp in the viral genome) and PstI (cuts within the polylinker of BlueScript). Nested deletions were generated by using an exonuclease III, S1 nuclease deletion kit (Erase-a-Base kit; Promega) according to the manufacturer's protocol. Appropriate size deletions were sequenced as described above in the presence of 7.5% dimethyl sulfoxide to help resolve sequence compressions.
DNA sequence analysis and analysis of putative gene products. Repeated sequences were identified within the finished sequences, using TANDEM and INVERTED (22a) . Initial analysis of the coding content of the genome was performed by using ACEDB (22b) . For analysis of individual open reading frames (ORFs), the genome was downloaded into VECTOR NTI version 4.0 Deluxe (Informax Inc., Gaithersburg, Md.). ORFs were translated in VECTOR NTI and downloaded to the National Center for Biotechnology Information (NCBI) BLAST server for analysis by BLASTP. Regions of the ␥HV68 nucleotide sequence were downloaded for analysis by BLASTN and BLASTX. Unless otherwise specified, default settings (including filters) were used for BLAST searches. Alignments between ␥HV68 ORFs and genes in other viruses, or host proteins, were analyzed by using the DNASTAR suite of programs (DNASTAR Inc., Madison Wis.). Alignments were performed with MegAlign, using the PAM250 residue weight table. Identities were determined from the PAM250 MegAlign alignments and are reported as the percentage of amino acids in a gene identical to the ␥HV68 sequence divided by the number of amino acids in the ␥HV68 ORF. Phylogenetic analyses were performed with MegAlign and the PAM250 weight table. Analysis of potential tRNA genes present in the ␥HV68 genome was carried out by using the tRNAscan-SE program (43a), which uses a modified, optimized version of tRNAscan version 1.3 (28) , coupled with a new implementation of a multistep weight matrix algorithm for identification of eukaryotic tRNA promoter regions (54) as well as the RNA covariance analysis package Cove version 2.4.2 (23) .
Assignment of ORFs and nomenclature. We initially scanned the viral genome for methionine-initiated ORFs encoding putative proteins at least 100 amino acids in length. Each of these ORFs was searched versus the nonredundant NCBI database, using the BLASTP algorithm and default settings, between January 1 and January 30, 1997. Viral and/or host homologs of all ␥HV68 ORFs with significant scores were downloaded for alignment and analysis. Subsequently, a list of genes in HVS that were not found in the ␥HV68 sequence by using the initial criteria was compiled. The presence of these genes was reevaluated by searching regions of the ␥HV68 genome (assuming the HVS gene order) and analyzing all methionine-initiated ORFs encoding proteins at least 50 to 60 amino acids in length, using BLASTP. In addition, these regions of the ␥HV68 genome were screened by using BLASTX to assess the presence of short ORFs with homology to HVS genes not identified by the previous searches. These approaches were successful in identifying several homologs of HVS ORFs that were missed on the initial search due to their short length. ORFs with homology to previously described gammaherpesvirus genes and ORFs were named for their HVS and KSHV homologs. After assignment of ORFs with known viral homologs, we examined the remaining 100 amino acid ORFs, using the following criteria. We evaluated whether the nucleotide sequences encoding these ORFs overlapped by more than 30% the nucleotide sequences encoding ORFs with homology to HVS, KSHV, and/or EBV genes. If ORFs overlapped known ORFs by less than 30%, we concluded that they might represent ␥HV68-specific ORFs and designated them M ORFs (for murine ␥HV68 putative ORFs). ORFs that overlapped more extensively with ORFs encoding homologs of known gammaherpesvirus proteins are not reported. This method of analysis does not address the possibility of gene products smaller than 100 amino acids in length or those that arise from splicing small ORFs and thus is most likely a conservative estimate of the number of genes encoded by ␥HV68.
GenBank accession number. The complete sequence of the unique region of the ␥HV68 genome has been deposited in the NCBI database. The accession number is GAMMAHV U97553.
RESULTS AND DISCUSSION
Primary structure of the ␥HV68 genome. Sequences from 2,336 random M13 bacteriophage recombinants (and additional clones described below) were assembled into a contiguous sequence (contig) representing the entire unique region of the ␥HV68 genome linked to a copy of the 1,213-bp terminal repeat at the right end of the unique sequence ( Fig. 1 ; total length of the contig is 119,450 bp). The linear organization of the genome was deduced from the previous characterization of the ␥HV68 genome (25) , which demonstrated the presence of multiple 1.2-kb direct repeats (terminal repeats) flanking the unique region of the genome. Based on the orientation of the HVS and KSHV genomes, the first base pair of unique sequence on the left end of the genome adjacent to the terminal repeat was assigned nucleotide position 1. The length of the unique region of the genome was determined from the sequence to be 118,237 bp, in close agreement with the 118 kb predicted by physical mapping of the ␥HV68 genome (25) . The previously deduced BamHI, HindIII, and EcoRI restriction endonuclease maps of the genome matched closely those predicted from the nucleotide sequence ( Fig. 1A and reference 25). Exceptions were several small fragments not previously observed: (i) a 209-bp HindIII fragment (HindIII a) between the HindIII H and Y fragments, (ii) a 280-bp BamHI fragment (BamHI U) between the BamHI K and A2 fragments, and (iii) a 53-bp EcoRI fragment (EcoRI U) between the EcoRI NI* and B fragments (Fig. 1A) .
The unique region of the genome is ca. 46% GϩC, while the terminal repeat is 77.6% GϩC. This is comparable to the 53.5% GϩC content of the unique region and 84.5% GϩC content of the terminal repeats of KSHV (61) . Similarly, the GϩC content of the unique region of equine herpesvirus 2 (EHV2) is 58% (70) . However, the GϩC contents of the unique region of both ␥HV68 and KSHV are significantly higher than the 34.5% GϩC content of the unique region of HVS (3). Similar to both ␥HV68 and KSHV, the terminal repeat of HVS is very GϩC rich (70.8%) (3) .
Analysis of putative ORFs in ␥HV68. Computer sequence analysis predicted the presence of 80 ORFs in the ␥HV68 genome ( Fig. 1 and Table 1 ). The basis for assigning ORFs was (i) ATG-initiated ORFs predicted to encode a minimum of 100 amino acids (exceptions were made in cases where a known or predicted gene product is encoded by another gammaherpesvirus), (ii) significant sequence homology to other known viral or cellular genes, and/or (iii) less than a 30% overlap with ORFs defined by the first two criteria. These predicted ORFs are shown relative to the ␥HV68 map in Fig.  1 . Table 1 summarizes their locations in the genome, predicted polypeptide sizes, and percent sequence identities to KSHV, HVS, and EBV gene products. Putative gene products with homology to HVS gene products were assigned the HVS/ KSHV gene number (i.e., ORF 4 corresponds to HVS gene 4), while ␥HV68 ORF products which are not obvious homologs of other gammaherpesvirus genes were designated M ORFs (e.g., M1 [ Fig. 1 and Table 1] ). It is likely that this ORF analysis reflects a conservative estimate of the genes encoded by ␥HV68 since numerous small ORFs which did not meet these criteria are not represented in Table 1 and Fig. 1 . Furthermore, this analysis would not detect spliced genes containing either short (Ͻ300 bp) or non-ATG-initiated ORFs.
Of the 80 ORFs identified in the ␥HV68 genome, 63 are
FIG. 1. Organization and ORF analysis of the ␥HV68 genome. (A) Predicted
BamHI, EcoRI, and HindIII restriction endonuclease cleavage maps of the ␥HV68 genome based on the complete nucleic acid sequence. With the exception of several small fragments (BamHI U, HindIII a, and EcoRI U), the predicted maps closely match the published analysis of Efstathiou et al. (25) . Asterisks indicate fragments at the ends of the genome map which have an undefined size due to the presence of a variable number of terminal repeats. (B) ORFs and tRNA-like genes present in the ␥HV68 genome. The ␥HV68 genome is composed of a 118,237-bp unique region (shown as the thick blue line) flanked by multiple copies of a 1,213-bp terminal repeat (depicted as open rectangles at the ends of the genome). In addition, there are two internal repeats within the unique region, which are shown in yellow. The criteria for selecting candidate ORFs are described in the text. Those ORFs with substantial homology to genes present in the HVS and KSHV genomes were assigned the corresponding HVS/KSHV gene number. Rightward ORFs of HVS homologs are depicted in blue, while leftward ORFs of HVS homologs are depicted in green (with the exception of those which are homologs of known cellular genes). ␥HV68 ORFs with no obvious homology to any other gammaherpesvirus genes were designated M ORFs (M1 to M14). ␥HV68 ORFs which are homologs of known cellular genes or of genes in viruses other than HVS, KSHV, and EBV are depicted in red. Those M ORFs which do not exhibit significant homology to any known cellular or viral gene products are indicated in purple. Also shown clustered near the left end of the unique region are eight potential tRNA-like genes (see Table 2 for details). homologs of HVS genes, all of which are also present in the KSHV genome and many of which are present in the EBV genome (Table 1) . One ORF, K3, appears to be present in the KSHV and ␥HV68 genomes but not in the HVS or EBV genome. The overall identity of ␥HV68 ORFs to their homologs in the other gammaherpesviruses indicates that ␥HV68 is more closely related to HVS and KSHV than to EBV (Table  1 ). However, at the level of individual ORFs, there is considerable variability in the extent of homology, and there are several ORFs for which the putative ␥HV68 ORF product is most closely related to the EBV gene product (see below). It should be noted that we assigned ␥HV68 genes as homologs of other gammaherpesvirus genes only when BLASTP analyses identified regions of homology (see Materials and Methods). Thus, for example, the ␥HV68 M9 ORF may be the homolog of HVS and KSHV ORF 65 and/or EBV BFRF3, but none of these gene products were sufficiently homologous to the putative ␥HV68 M9 gene product to score in the BLASTP search. There was generally good size conservation between ␥HV68 ORFs and those in KSHV, HVS, and EBV (Table 1) . One exception is ORF 57 of ␥HV68, which is significantly shorter than the KSHV, HVS, and EBV homologs. On further analysis, we found that ORF 57 is open upstream of the ATG at position 76662, which was used to calculate the size of the putative ORF 57 protein (Table 1) . A BLASTP search of the ORF upstream of position 76662 revealed significant homology to HVS gene 57. In addition, alignment of this upstream region demonstrated significant homology with portions of the HVS and KSHV gene 57 proteins and the EBV BMLF1 gene. This finding suggests that ␥HV68 ORF 57 may be a spliced gene, with the ATG-initiated ORF in Table 1 present as the C-terminal portion of a longer ORF 57 product.
It is also notable that there are three copies of ORF 75, which encodes the enzyme N-formylglycinamide ribotide amidotransferase. Interestingly, HVS also contains an additional copy of this gene (ORF 3). However, the other characterized gammaherpesviruses appear to encode only a single copy of ORF 75. The significance of multiple copies of this gene in ␥HV68 and HVS in the biology of these viruses is not readily apparent.
In general, the ␥HV68 ORFs are very closely spaced on the genome ( Fig. 1 and Table 1 ). The exception to this is near the left end of the unique region, where the presence of ORFs which meet the criteria described above is relatively sparse. As discussed below, this may be notable since among the gammaherpesviruses, this region is very divergent and, in the cases of EBV and HVS, is known to encode transformation-associated gene products (6, 21, 32, 37, 39, 47, 50) . At the left end of the ␥HV68 genome, five short (40-to 104-bp) sequences with significant homology to multiple (at least three different) bacterial tRNAs were detected by a BLASTN search of bp 1 to 10000 of the genome (Fig. 1 ). Additional sequences with some homology to a single bacterial tRNA were also found in this region. BLASTN searches of the remainder of the genome did not reveal any additional tRNA-like sequences. The first 10,000 bp of the genome was further evaluated by using the tRNAscan-SE program (see Materials and Methods), which predicted the presence of eight tRNA-like genes ( Table 2 ). The role of these putative tRNA-like molecules in the ␥HV68 life cycle is not clear, and it is possible that they do not function as tRNAs since five of the eight tRNA-like genes lack clear anticodons (Table 2) . Interestingly, the putative tRNAs are encoded in a region positionally homologous to the region encoding the HVS U-RNAs (2, 3, 31, 50).
Three of the ␥HV68-specific ORFs (M12, M13, and M14) are partially or entirely encoded within the terminal repeat (below). The significance of this remains to be determined, since the high GϩC content of the terminal repeats may predict the presence of ORFs which are not actually transcribed. Similarly, three overlapping ORFs (M10a, M10b, and M10c) which are largely encoded within the 100-bp repeat were detected. These share a common repetitive sequence encoded by the 100-bp repeat but are predicted to contain unique carboxy termini. In addition, M10a is predicted to have a unique amino-terminal sequence (compared to ORFs M10b and M10c) since this ORF initiates 78 bp to the left of the 100-bp repeat. ORF M6 spans the 40-bp repeat and is predicted to have a repetitive amino acid sequence. Analysis of repeats in the ␥HV68 genome. In addition to the terminal repeat, the ␥HV68 genome contains two internal repeats (Fig. 2) , a 40-bp repeat located between bp 26778 and 28191 in the genome and a 100-bp repeat located between bp 98981 and 101170 in the genome. Both repeats are very GϩC rich; the 100-bp repeat is 86% GϩC, while the 40-bp repeat is 83% GϩC.
(i) The 100-bp repeat. The region of the 100-bp repeat ( Fig.  2A) was constructed by combining the following data: (i) sequences of multiple M13 clones spanning the left and right junctions between the 100-bp repeats and unique sequence, (ii) sequencing a series of exonuclease III-generated nested deletions spanning the 100-bp repeat region (see Materials and Methods), and (iii) estimation of the size of the repeat region (cloned from genomic DNA) by restriction endonuclease digestion. These multiple pieces of data were required because the highly repetitive nature and size of the region prevented us from obtaining unambiguous sequence from M13 clones alone. This was due to our inability to unambiguously anchor sequences initiating within the 100-bp repeat in the contig. The 100-bp repeat is predicted to span from bp 98981 to 101170 and to contain 21 complete copies of the 100-mer repeat shown in Fig. 2A and a 90-bp partial repeat at the right end of the 100-bp repeat region.
(ii) The 40-bp repeat. The region of the 40-bp repeat was constructed by using the following data: (i) sequences of multiple M13 clones spanning the left and right borders between the 40-bp repeats and unique sequence and (ii) estimation of the size of the repeat region (derived from genomic DNA) by restriction endonuclease digestion analyses. We failed to stably clone the 40-bp repeat region; numerous clones were recovered, all of which had spontaneously deleted portions of the repeat. M13 clones spanning the left junction between unique sequence and the repeat region entered into a series of 40-bp repeats each containing a BamHI site (type A repeats [ Fig.  2B] ). The first A repeat at the left-hand end is a partial repeat containing the last 27 bp of the type A repeat. M13 clones spanning the right junction between unique sequence and the repeat region spanned several repeats that were similar in structure to the A repeats (B, C, D, and E repeats [ Fig. 2B]) prior to entering A repeats. The rightmost two repeats (type E repeats) are 41-mers that lack the internal BamHI site. There is also a slightly longer 51-bp variant (type D repeat) which contains the internal BamHI site and two other 41-mer variants (type B and C repeats) which also contain the internal BamHI site. We concluded that the majority of the repeat is composed of an estimated 27 copies of the 40-mer A repeat (Fig. 2B ) based on the fact that M13 clones from both right and left junctions between unique sequence and repeat sequence end with 40-bp repeat A sequences. It is possible that other sequences that could not be detected by our analysis are present centrally within the 40-bp repeat sequence. It is perhaps notable that all variant repeats which were detected map to the right end of the repeat, suggesting that maintaining the integrity of the central and left-hand portions of this repeat region may be functionally important.
(iii) The terminal repeat. The terminal repeat was sequenced multiple times from M13 clones spanning the 5Ј and 3Ј junctions between unique sequence and the terminal repeats. A single copy of the 1,213-bp terminal repeat is attached to the right end of the ␥HV68 unique sequence submitted to GenBank. It should be noted that the beginning of the consensus terminal repeat unit was defined by the border between the terminal repeat and nucleotide 1 of the genome. This assignment, based on the sequences of M13 clones spanning the right-hand junction between unique sequence and the terminal repeat, results in a 26-bp portion of the terminal repeat at the right-hand end of the unique region of the ␥HV68 genome before the first intact terminal repeat. As discussed above, the terminal repeat encodes a putative polypeptide (M14) which would be initiated from one of two potential methionine initiation codons present in this very GϩC rich sequence, thus generating an ORF which is represented many times in the intact viral genome. In addition, two ORFs (M12 and M13) begin outside the terminal repeat but extend into the terminal repeat. We also evaluated the left end of the genome attached to the terminal repeat but found no ORFs meeting our criteria (see above). The significance of these putative ORFs that include GϩC-rich terminal repeat sequences is not known.
Comparison of genome organization among gammaherpesviruses. The genomes of herpesviruses tend to contain blocks of conserved genes interspersed with blocks of genes specific to a viral family or a specific virus (17) . In agreement with the close structural homology between the ␥HV68 genome and the genomes of KSHV, HVS, and EBV, phylogenetic analyses of the predicated DNA polymerase and major capsid proteins supported the assignment of ␥HV68 as a gammaherpesvirus (data not shown) (17, 38) . To further assess the relationship between ␥HV68 and primate gammaherpesviruses, we compared the gene organizations of HVS, KSHV, ␥HV68, and EBV genomes. This analysis revealed a strong conservation of specific blocks of genes, separated by genes that appear to be largely virus specific (Fig. 3) . None of the EBV latency-associated genes (i.e., the EBNA or LMP genes) appears to be conserved among the gammaherpesviruses. In addition, the trans- formation-associated HVS gene products STP and TIP do not appear to have homologs in the other gammaherpesviruses. This observation raises the possibility that many of the latencyand transformation-associated genes in ␥HV68 and KSHV are encoded by virus-specific genes. In addition, it suggests that while functions required for lytic replication of these viruses have generally been well conserved, strategies for latency have diverged significantly. This may reflect both cell-type-and speciesspecific constraints. Alternatively, it is possible that the ability of gammaherpesviruses to establish a latent infection has independently evolved in each of these viruses. The latter possibility seems unlikely given that the ability to establish a latent infection is a hallmark of all characterized herpesviruses.
Homologs of cellular or viral genes potentially involved in pathogenesis, latency, or tumor induction. It is notable that ␥HV68 contains homologs of several viral and host genes that may be important for gammaherpesvirus pathogenesis (Fig. 4) . Similar to HVS and KSHV, ␥HV68 contains an ORF (ORF 4) with significant homology to multiple complement regulatory proteins (3, 42, 61) . The presence of four regions within ␥HV68 ORF 4 with homology to complement control protein repeats or short consensus repeats results in significant BLASTP alignments with many complement regulatory proteins (42) . Notably, ␥HV68 ORF 4 aligns particularly well over the entire length of the predicted protein with murine decayaccelerating factor (DAF) and human membrane cofactor protein (MCP) (Fig. 4A) . Both DAF and MCP regulate C3 convertase (although by different mechanisms), suggesting that regulation of C3 convertase is a potential action of ORF 4 of ␥HV68. This hypothesis is consistent with studies of the HVS gene 4 product, which inhibits C3-mediated lysis (29) .
ORF 72 of ␥HV68 is predicted to encode a D-type cyclin. The fact that KSHV, HVS, and ␥HV68 encode cyclin homologs (13, 16, 36, 41, 51) , combined with the fact that EBV regulates cellular cyclin D expression (62) , strongly argues for a conserved role of this gene product in gammaherpesvirus biology. An alignment of the ␥HV68 ORF 72 with mouse cyclin D1, KSHV v-cyclin, and HVS v-cyclin is shown in Fig.  4B . The proteins all share conserved residues (e.g., the ␥HV68 TWM sequence at position 62 in the alignment) within the cyclin box. A mutagenesis study of this region of the HVS v-cyclin showed that several residues conserved between ␥HV68 ORF 72 and the HVS v-cyclin are involved in binding to cyclin-dependent kinase 6 (cdk6) (36) . In addition, the 
FIG. 4. Alignments of five ␥HV68
ORFs with viral or host homologs. All alignments were performed with MegAlign (DNASTAR) and are presented without reediting after the initial alignment was performed. Residues shown in green are chemically related, while red indicates the presence of identical residues among some of the sequences (at some positions both red and green highlighted residues are shown, which indicates that all of the colored residues are chemically related and some of them are identical). Blue denotes those residues which are identical in all the aligned protein sequences. For each of the alignments described below, the number in parentheses is the GenBank or SWISS-PROT accession number (GB or SP acc.). All HVS, KSHV, and EBV sequences were derived from the original publications (3, 6, 61) KSHV v-cyclin associates with cdk6 and to a lesser extent with cdk4 (41) . These data suggest that the ␥HV68 v-cyclin may also interact with specific cyclin-dependent kinases. Interestingly, we have not found a clear homolog of the LxCxE motif found to be important for retinoblastoma protein binding to cyclin D (22, 27) . Notably, this motif is also lacking in the HVS and KSHV v-cyclins, raising the possibility that the v-cyclins do not interact with the retinoblastoma protein. Alternatively, it is possible that additional exons are spliced to the viral ORF 72 to form a protein containing the LxCxE motif (or other sequences). The fact that KSHV and HVS v-cyclins are expressed in Kaposi's sarcoma tissues (13) and transformed cell lines (36) , respectively, raises the possibility that the ␥HV68 v-cyclin is involved in oncogenesis or latency. However, a role in lytic infection has not been ruled out by studies to date of the HVS and KSHV v-cyclins.
␥HV68 ORF M11 has weak overall homology to bcl-2 family members and encodes a protein with 24% amino acid identity with the EBV BHRF1 gene product (Fig. 4C) . The latter has been shown to inhibit apoptosis in several systems (33, 69) . Similarly, the KSHV bcl-2 homolog (gene 16) inhibits apoptosis (14) . We designated this ORF M11 rather than calling it either ORF 16 (as a homolog of the HVS and KSHV gene 16) or BHRF1, since the level of homology is weak enough that the proteins could have distinct functions (Fig. 4C) . It is clear from a survey of the known viral Bcl-2 homologs that there is only limited sequence conservation between these proteins and the cellular counterparts. Thus, it is perhaps not surprising that the viral bcl-2 genes may have also diverged significantly from each other. The greatest local homology between Bcl-2 family members and the ␥HV68 M11 ORF product is within the box 1 motif involved in dimerization of Bcl-2 family members (data not shown). This raises the possibility that ␥HV68 M11 functions by interacting with itself or host Bcl-2 family members, although this type of association may not be essential for the KSHV gene 16 product to inhibit apoptosis (14) .
It is notable that the ␥HV68 M11 ORF (potential bcl-2 homolog) is located in the same position in the genome as the EBV bcl-2 homolog (BHRF1 gene). Thus, EBV and ␥HV68 have a common arrangement of their bcl-2 homologs. Notably, while the KSHV bcl-2 homolog (gene 16) is located in the same place as the HVS gene 16, the KSHV bcl-2 homolog is adjacent to an HVS gene 70 homolog (Fig. 3) . This finding suggests that in an ancestral gammaherpesvirus, the bcl-2 homolog was located near the right-hand end of the unique region (near gene 70). Rearrangement of this ancestral genome could have moved the bcl-2 homolog to its current location in the HVS and KSHV genomes. In the case of KSHV, this speculative rearrangement included gene 70. This argues for placement of the ancestral bcl-2 homolog in the same position as the ␥HV68 M11 and EBV BHRF1 genes.
␥HV68 also contains an ORF (M1) which is predicted to encode a protein homologous to several poxvirus serpins (Fig.  4D ). This ORF product is the first reported serpin homolog encoded by a herpesvirus. The fact that similar ORFs have not been found in HVS, KSHV, and EBV suggests that this ORF may provide a virus-or host-specific function unique to ␥HV68. Significant homology was found between ␥HV68 M1 and the SPI-1 genes of rabbitpox, cowpox, vaccinia, and variola viruses (Fig. 4D) (4) . Interestingly, the poxvirus SPI-1 gene can regulate host cell range by altering apoptosis (9) . There is also significant homology between the ␥HV68 M1 ORF and crmA (Fig. 4D) (59) . This raises the possibility that the ␥HV68 serpin may alter the function of interleukin 1 (IL-1)-converting enzyme-like proteases. It is notable that poxvirus serpins have been implicated in a broad range of processes in addition to regulating apoptosis, including regulation of inflammatory responses and altering arachidonate (4, 9, 18, 44, 52, 53, 56, 59, 72) . The specific role of viral serpins may depend on the enzyme(s) targeted (43) and the host pathogenesis model evaluated (71) .
␥HV68 contains an ORF (ORF 74) homologous to genes encoding G-protein-coupled receptors (GCRs). Similar to gene 74 in both HVS and KSHV, the ␥HV68 ORF 74 is most homologous to the IL-8 receptor (Fig. 4E) (1, 3, 5, 51, 61) . Structure analysis demonstrates seven potential transmembrane domains (not shown). The HVS ORF 74 product has been shown to be a functional IL-8 receptor in transfection experiments (1) . This finding suggests the possibility that host cytokines signaling through the viral GCR could alter the virus life cycle. In contrast, the KSHV gene 74 product is a constitutively active GCR that can bind both ␣ and ␤ chemokines and can provide a signal for cell growth (5) . As the KSHV gene has been demonstrated to be expressed in tumors (13) , it is possible that these receptors play a role in tumor induction or maintenance of tumor growth. However, a role in latency or lytic infection is also possible.
␥HV68 contains an ORF (K3) homologous to ORFs K3 and K5 of KSHV as well as the bovine herpesvirus 4 major immediate-early (BHV4 IE1) transcript (61, 75) . The homology between KSHV K3, KSHV K5, ␥HV68 K3, and BHV4 IE1 is local and is marked by complete conservation of a motif CWIC-(10/11x)-CxCxxxxxxxHxxCxxxWxxxSxxxxCxxCxxxY. Interestingly, this motif is also present in a hypothetical swinepox virus protein (C7; SWISS-PROT accession no. P32225) and is well conserved in the amino-terminal portion of the Caenorhabditis elegans F58E6.1 protein (EMBL accession no. Z70754). This is an additional example (together with the serpin homolog described above) of conservation between poxvirus and herpesvirus genes. The importance of this motif is not known, but it may represent a part of a zinc finger motif. Conservation of this motif across multiple viruses and C. elegans suggests an important role in the function of these proteins.
Summary. The complete nucleotide sequence of the ␥HV68 genome demonstrates that this murine herpesvirus is a gammaherpesvirus with similarities to HVS, KSHV, and EBV. The presence of cyclin, GCR, serpin, Bcl-2, and DAF/MCP homologs provides an opportunity to evaluate the roles of the genes encoding these proteins in viral pathogenesis. In addition, the identification of a number of apparently virus-specific ORFs in the ␥HV68 genome offers the opportunity to assess their contribution to ␥HV68 pathogenesis, latency, and tumor induction in a tractable small-animal model.
